天益医疗
(301097)
| 流通市值：7.43亿 | | | 总市值：23.89亿 |
| 流通股本：1834.74万 | | | 总股本：5894.74万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 96,914,552.27 | 380,921,993.55 | 275,269,865.85 | 179,215,683.89 |
| 营业收入 | 96,914,552.27 | 380,921,993.55 | 275,269,865.85 | 179,215,683.89 |
| 二、营业总成本 | 93,815,124.46 | 343,166,468.58 | 237,117,489.86 | 144,594,043.89 |
| 营业成本 | 62,213,777.91 | 238,247,031.83 | 174,744,244.27 | 107,947,896.4 |
| 税金及附加 | 956,753.85 | 5,263,939.09 | 4,209,863.51 | 2,803,527.03 |
| 销售费用 | 2,818,366.35 | 15,500,432.2 | 8,502,142.29 | 5,123,322.32 |
| 管理费用 | 19,095,196.57 | 59,869,441.94 | 38,761,628.66 | 22,740,733.27 |
| 研发费用 | 10,309,491.39 | 31,095,808.89 | 20,725,295.4 | 13,483,450.89 |
| 财务费用 | -1,578,461.61 | -6,810,185.37 | -9,825,684.27 | -7,504,886.02 |
| 其中:利息费用 | 2,368,764.66 | 9,896,838.72 | 7,859,944.44 | 5,106,045.8 |
| 其中:利息收入 | 3,521,638.74 | 12,727,653.4 | 11,296,856.26 | 3,256,805.81 |
| 加:公允价值变动收益 | 2,271,952.71 | 5,005,279.09 | 3,634,506.77 | 14,599,462.47 |
| 加:投资收益 | 274,715.74 | 24,450,548.71 | 22,672,814.45 | 8,633,240.8 |
| 资产处置收益 | -223,143.15 | -52,158.51 | 30,170.08 | 38,446.45 |
| 资产减值损失(新) | -18,726.75 | -456,041.64 | -446,810.91 | -283,854.99 |
| 信用减值损失(新) | 105,962.41 | 509,084.85 | 780,669.13 | 985,991.03 |
| 其他收益 | 363,080.65 | 2,473,145.72 | 1,693,700.37 | 1,505,077.63 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 5,873,269.42 | 69,685,383.19 | 66,517,425.88 | 60,100,003.39 |
| 加:营业外收入 | 13,419.28 | 2,439,890.16 | 5,144,982.44 | 1,038,292 |
| 减:营业外支出 | 20,223.51 | 24,833.05 | 23,093.06 | 20,243.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 5,866,465.19 | 72,100,440.3 | 71,639,315.26 | 61,118,051.45 |
| 减:所得税费用 | 1,685,519.89 | 11,950,580.92 | 10,667,043.56 | 9,354,068.15 |
| 六、净利润 | 4,180,945.3 | 60,149,859.38 | 60,972,271.7 | 51,763,983.3 |
| 持续经营净利润 | 4,180,945.3 | 60,149,859.38 | 60,972,271.7 | 51,763,983.3 |
| 归属于母公司股东的净利润 | 5,406,482.66 | 63,569,979.84 | 61,027,949.1 | 52,136,985.04 |
| 少数股东损益 | -1,225,537.36 | -3,420,120.46 | -55,677.4 | -373,001.74 |
| (一)基本每股收益 | 0.09 | 1.08 | 1.04 | 0.89 |
| (二)稀释每股收益 | 0.09 | 1.08 | 1.04 | 0.89 |
| 八、其他综合收益 | -569,734.54 | -543,275.52 | 131,435.95 | 311,765.57 |
| 归属于母公司股东的其他综合收益 | -569,734.54 | -754,077.47 | 144,881.7 | 227,221.71 |
| 九、综合收益总额 | 3,611,210.76 | 59,606,583.86 | 61,103,707.65 | 52,075,748.87 |
| 归属于母公司股东的综合收益总额 | 4,836,748.12 | 62,815,902.37 | 61,172,830.8 | 52,364,206.75 |
| 归属于少数股东的综合收益总额 | -1,225,537.36 | -3,209,318.51 | -69,123.15 | -288,457.88 |
| 公告日期 | 2024-04-25 | 2024-04-24 | 2023-10-25 | 2023-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |